Nitazoxanide: A potential novel agent for hepatitis C Darryn PotoskyCharles Howell Clinical Trials Report 06 May 2009 Pages: 39 - 40
Optimizing peginterferon and ribavirin administration in difficult-to-treat patient populations Carmen LandaverdeSammy Saab OriginalPaper 06 May 2009 Pages: 43 - 51
Novel drugs for hepatitis C virus William W. ShieldsPaul J. Pockros OriginalPaper 06 May 2009 Pages: 52 - 58
Hepatitis C and hepatocellular carcinoma: New developments in natural history and treatment Joseph AhnSteven L. Flamm OriginalPaper 06 May 2009 Pages: 59 - 65
STAT-C: New therapies cannot get here fast enough Giuseppe MorelliDavid R. Nelson OriginalPaper 06 May 2009 Pages: 73 - 80
Treatment of hepatitis C in the potential liver transplant recipient Hui-Hui TanThomas D. Schiano OriginalPaper 06 May 2009 Pages: 81 - 86